Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Exchange Rate Effect came in at -$25.0 million in Q1 2026, down 135.71% year-on-year from $70.0 million in Q1 2025, and down 208.7% quarter-over-quarter from $23.0 million in Q4 2025.

Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Exchange Rate Effect across 18 years of filings, most recently posting -$25.0 million for Q1 2026.

  • Exchange Rate Effect for Q1 2026 came in at -$25.0 million, down 135.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.0 million (up 212.77% YoY), and the FY2025 annual result was $201.0 million, up 169.55% from the prior year.
  • Exchange Rate Effect came in at -$25.0 million for Q1 2026 at Johnson & Johnson, down from $23.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $154.0 million in Q2 2025 to a low of -$198.0 million in Q4 2024.
  • The 5-year median for Exchange Rate Effect is -$25.0 million (2026), against an average of -$26.4 million.
  • Across the five-year window, Exchange Rate Effect sank 546.43% in 2024 and jumped 281.18% in 2025, its largest moves.
  • Johnson & Johnson's Exchange Rate Effect stood at $16.0 million in 2022, then jumped by 681.25% to $125.0 million in 2023, then slumped by 258.4% to -$198.0 million in 2024, then jumped by 111.62% to $23.0 million in 2025, then plunged by 208.7% to -$25.0 million in 2026.
  • The last three Exchange Rate Effect figures came in at -$25.0 million (Q1 2026), $23.0 million (Q4 2025), and -$46.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FX Effect (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 2.70 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 67.00 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -25.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -12.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -19.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -11.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 19.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -48.00 Mn
10 Novartis Ag 109.78 Bn 109.09 Bn - -77.00 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 -25.00 Mn
Mar 29, 2026 -25.00 Mn
Dec 28, 2025 23.00 Mn
Dec 28, 2025 23.00 Mn
Sep 28, 2025 -46.00 Mn
Sep 28, 2025 -46.00 Mn
Jun 29, 2025 154.00 Mn
Jun 29, 2025 154.00 Mn
Mar 30, 2025 70.00 Mn
Mar 30, 2025 70.00 Mn
Dec 29, 2024 -198.00 Mn
Dec 29, 2024 -198.00 Mn
Sep 29, 2024 119.00 Mn
Sep 29, 2024 119.00 Mn
Jun 30, 2024 -85.00 Mn
Jun 30, 2024 -85.00 Mn
Mar 31, 2024 -125.00 Mn
Mar 31, 2024 -125.00 Mn
Dec 31, 2023 125.00 Mn
Dec 31, 2023 125.00 Mn